.png)
.png)
.jpg "henry chambers, MD photo")
Professor
University of California, San Francisco, and San Francisco General Hospital
Disclosure(s): Merck: DSMB member, Stocks/Bonds; Moderna: Stocks/Bonds
Dr. Chambers graduated from Vanderbilt University School of Medicine in 1977. He trained in Internal Medicine and Infectious Diseases at the University of California San Francisco. He was also a Kaiser Foundation Fellow in General Internal Medicine at UCSF and a post-doctoral research fellow at Rockefeller University. Dr. Chambers is Professor of Medicine, Emeritus, and Medical Director of Clinical Research Services for the UCSF Clinical Translational Science Institute. He served as Chief of Infectious Diseases at San Francisco General Hospital from 1992-2013 and Director of the UCSF Infectious Diseases Fellowship Training Program from 2002-2013. He is a Fellow of the Infectious Diseases Society of America (IDSA) and of the American College of Physicians and was elected to membership in the American Society of Clinical Investigation and the American Association of Physicians. He is editor for the Sanford Guide to Antimicrobial Therapy and he has over 200 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections, and staphylococcal diseases. He is a reviewer for numerous medical publications. He has been a member of advisory groups for the Centers for Diseases Control and Prevention, a chair and reviewer for NIH study sections, and a member of the IDSA treatment guidelines committees. He is a past member of the IDSA board of directors. He and Dr. Vance Fowler are Co-Principal Investigators of the Antibacterial Resistance Leasdership Group. His clinical and research interests are antimicrobial drug resistance, staphylococcal infections, experimental therapeutics, and epidemiology and pathogenesis of disease caused by community methicillin-resistant Staphylococcus aureus.